openPR Logo
Press release

Kaposi Sarcoma Treatment Market Drivers

08-27-2018 04:14 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma is one of the major factors driving the adoption of Highly Active Antiretroviral Therapy (HAART) therapy, which subsequently drives growth of the Kaposi sarcoma treatment market. For instance, according to the American Cancer Society (ACS), February 2016 data findings, around 1 in 200 transplant patients in the U.S. suffer from Kaposi sarcoma. In the U.S., Kaposi sarcoma is much more common among men than women, and is rarely observed among children. Additionally, according to the same source, it is more common among African Americans than in whites in the U.S in 2016.

However, lack of awareness about this cancer, irregular availability of chemotherapy and HAART, lack of radiotherapy services, and overall high cost of cancer treatment are major factors limiting growth of the Kaposi sarcoma treatment market. For instance, according to the data published by Monash University Malaysia in January 2016, the prices of major drugs used for the treatment of Kaposi sarcoma, such as liposomal doxorubicin, liposomal daunorubicin, or paclitaxel in combination with HAART, are increasing significantly, making them unaffordable for middle- and lower-income group patients.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1671

Kaposi Sarcoma Treatment Market - Regional Analysis

On the basis of region, the Kaposi sarcoma treatment market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds a leading position in the global Kaposi sarcoma treatment market, owing to the presence of various key players in the region and the rising cost of Kaposi sarcoma treatment drugs. The North America market for also benefits from the high rate of diagnosis of the sarcoma condition.

Moreover, North America is witnessing a shortage in supply of drugs required for its treatment, leading to a wide demand-supply gap and subsequently significant slower scope for growth. For instance, in January 2016, Eisai Co., Ltd. issued the shortage notice by stating that, due to the manufacturing issue, there was a supply shortage of Panretin gel tubes (US FDA approved) in U.S. Moreover, in order to alleviate the shortage of Panretin gel in the U.S., FDA approved the sales of Panretin gel tubes for use in the European market.

Download The PDF Brochure:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kaposi Sarcoma Treatment Market Drivers here

News-ID: 1204108 • Views: 369

More Releases from Coherent Market Insights

Cryptocurrency Mining Equipment Market is Expected to Witness Stunning Growth Ti โ€ฆ
๐—ง๐—ต๐—ฒ ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฐ๐—ฟ๐˜†๐—ฝ๐˜๐—ผ๐—ฐ๐˜‚๐—ฟ๐—ฟ๐—ฒ๐—ป๐—ฐ๐˜† ๐—บ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ถ๐˜€ ๐—ฒ๐˜€๐˜๐—ถ๐—บ๐—ฎ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ฒ๐˜…๐—ต๐—ถ๐—ฏ๐—ถ๐˜ ๐—ฎ ๐—–๐—”๐—š๐—ฅ ๐—ผ๐—ณ ๐Ÿญ๐Ÿด.๐Ÿฒ๐Ÿด% ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐˜๐—ต๐—ฒ ๐—ณ๐—ผ๐—ฟ๐—ฒ๐—ฐ๐—ฎ๐˜€๐˜ ๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฑ. Summary of the Report - CMI's latest report, global "Cryptocurrency Mining Equipment Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Advanced Micro Devices, Inc., Russian Miner Coin, Halong Mining, Zhejiang Ebang Communication Co.,โ€ฆ
Traffic Management System Market is projected to show significant growth by 2027 โ€ฆ
๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ถ๐—ป๐—ด ๐˜‚๐—ฟ๐—ฏ๐—ฎ๐—ป๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ด๐—ฟ๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—ฝ๐˜‚๐—ฏ๐—น๐—ถ๐—ฐ ๐—ฐ๐—ผ๐—ป๐—ฐ๐—ฒ๐—ฟ๐—ป๐˜€ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜† ๐—ฎ๐—ฟ๐—ฒ ๐—บ๐—ฎ๐—ท๐—ผ๐—ฟ ๐—ณ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ด๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐˜๐—ฟ๐—ฎ๐—ณ๐—ณ๐—ถ๐—ฐ ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ Summary of the Report - CMI's latest report, global "Traffic Management System Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Atkins Group, Affiliated Computer Services, Inc., Alstom SA,โ€ฆ
Workplace Transformation Market Growth Opportunities, SWOT Analysis, Know the Co โ€ฆ
๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ถ๐—ป๐—ด ๐—ฎ๐—ฑ๐—ผ๐—ฝ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ป๐—ฒ๐˜„ ๐˜๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ด๐—ฒ ๐—ถ๐—ป ๐˜„๐—ผ๐—ฟ๐—ธ ๐—ฐ๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฒ๐—ป๐˜๐—ฒ๐—ฟ๐—ฝ๐—ฟ๐—ถ๐˜€๐—ฒ๐˜€ ๐—ฎ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—ธ๐—ฒ๐˜† ๐—ณ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐—ด๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜„๐—ผ๐—ฟ๐—ธ๐—ฝ๐—น๐—ฎ๐—ฐ๐—ฒ ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ Summary of the Report - CMI's latest report, global "Workplace Transformation Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - NTT Data Corporation , Cisco Systems, Inc.โ€ฆ
Automotive Lighting Market Demand, Overview, Size, Trend, and Key Players Names: โ€ฆ
๐—œ๐—บ๐—ฝ๐—น๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ป๐—ฒ๐˜„ ๐˜๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—น๐—ถ๐—ด๐—ต๐˜๐—ถ๐—ป๐—ด ๐—ถ๐˜€ ๐˜๐—ต๐—ฒ ๐—ผ๐—ป๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ธ๐—ฒ๐˜† ๐—ณ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ ๐—ฝ๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—น๐—น๐—ถ๐—ป๐—ด ๐—ด๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜. Summary of the Report - CMI's latest report, global "Automotive Lighting Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - General Electric, Magneti Marelli S.P.A, Koito Manufacturing Co. Ltd, Valeo, Hella KGaA Hueckโ€ฆ

All 5 Releases


More Releases for Kaposi

Kaposi Sarcoma Treatment Market Competitive Landscape
Kaposi sarcoma is a malignant tumor disease majorly associated with skin, mucous membranes, lymph nodes, and other organs. Kaposi sarcoma causes lesions to grow in the skin, in the mucous membranes lining the mouth, nose, and throat, lymph nodes, and other organs. Human herpesvirus-8 (HHV-8) is majorly found in the lesion of all patients suffering from Kaposi sarcoma. However, patients with weakened immune systems by Acquired Immune Deficiency Syndrome (AIDS)โ€ฆ
Kaposi Sarcoma Market Analysis & Trends 2024
The global market for Kaposi sarcoma is projected to expand at a modest 2.2% CAGR from 2016 to 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by the end of the forecast period. Hospitals formed the leading distribution channel in 2015, generating over US$40 mn revenue that year. The segment is also slated emerge as the fastest growing segment inโ€ฆ
Global Kaposi Sarcoma Market - Elite Demand and Research Trends
Qyresearchreports include new market research report Global Kaposi Sarcoma Market Size, Status and Forecast 2022 to its huge collection of research reports. The thorough report here condenses diverse perspectives having a place with the general Kaposi Sarcoma market which verbalizes the present-day data and future exposures with reference to the dynamic powers at play. The prime reason behind the examination report is to offer the endorser with a broad outline andโ€ฆ
Global Kaposi Sarcoma Market Trends & Industry Forecast by 2016 - 2024
Kaposi Sarcoma Market: Snapshot Kaposi sarcoma (KS) refers to a type of cancer that develops from the cells lining blood vessels or lymph nodes. The cancer usually appears as tumors on mucosal surfaces or on the skin, but can also develop in body parts such as the digestive tract, or the lungs. The abnormal KS cells cause brown, purple, or red blotches on the skin, called lesions. The global Kaposi sarcoma marketโ€ฆ
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry ofโ€ฆ
Kaposi Sarcoma Market: North America Leads Global Market despite Lower Incidence โ€ฆ
According to the U.S. Centers for Disease Control and Prevention, Kaposi sarcoma (KS) is considered to be an AIDS-defining disease, indicating that patients with KS go on to develop AIDS. The incidence of Kaposi sarcoma was reportedly high in homosexual men with HIV. The market for Kaposi sarcoma is characterized by the increasing number of domestic players playing an important role in their respective regional markets. Given the patent expiry ofโ€ฆ